121
Participants
Start Date
January 9, 2019
Primary Completion Date
April 15, 2021
Study Completion Date
June 28, 2022
Retifanlimab
Retifanlimab administered intravenously at 500 mg every 4 weeks
Universitatsklinikum St. Polten, Sankt Pölten
BAZ County Hospital, Miskolc
Ordensklinikum, Linz
Hetenyi G Korhaz, Onkologiai Kozpont, Szolnok
New York Oncology Hematology - Albany, Albany
Institut Paoli Calmettes, Marseille
CEPCM / CHU Timone, Marseille
Christiana Care Helen F. Graham Cancer Center, Newark
Rcca Md, Llc, Bethesda
Oncology & Hematology Associates of Southwest Virginia, Inc., Wytheville
ASST Istituti Ospitalieri, Cremona
MD Anderson Cancer Center Madrid, Madrid
Hospital Puerta De Hierro, Majadahonda
Institut Bergonié, Bordeaux
Hospital Universitari La Fe, Valencia
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
Azienda Ospedaliera Universitaria Senese, Siena
Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona
Hopitaux Universitaires De Strasbourg, Strasbourg
Georges Pompidou European Hospital, Paris
AIM Trials, LLC, Plano
Texas Oncology - Waco, Waco
Oncology and Hematology Associates of Southwest Virginia, Inc., The Woodlands
Texas Oncology - San Antonio Northeast, San Antonio
Coastal Bend Cancer Center, Corpus Christi
Texas Oncology Surgical Specialists - Austin Central, Austin
Rocky Mountain Cancer Centers - Denver - Midtown, Denver
California Cancer Associates for Research and Excellence, Inc., San Marcos
California Cancer Associates for Research and Excellence, Inc., Fresno
California Cancer Associates for Research and Excellence, Fresno
St Joseph Heritage Healthcare, Santa Rosa
St. Joseph Health Medical Group - Annadel Medical Group, Santa Rosa
Kaiser Permanente, Portland
Centrul de Oncologie Sfantul Nectarie, Craiova
Oncolab SRL, Craiova
Oncocenter - Oncologie Clinica SRL, Timișoara
Medisprof SRL, Cluj-Napoca
Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu
Center of Oncology Euroclinic, Iași
Clinical Emergency Hospital of Constanta, Constanța
VA New Jersey Health Care System, East Orange
LKH Graz, Graz
Med-Polonia Sp. z o. o., Poznan
Centrum Onkologii- Instytut im Marii Skłodowskiej Curie, Warsaw
Medizinische Universitat Innsbruck, Innsbruck
Istituto Nazionale Tumori Regina Elena, Rome
Specjalistyczna Praktyka Lekarska, Lublin
BioVirtus Research Site, Otwock
Hospital Universitari Parc Tauli, Sabadell
Centro Oncologico De Galicia, A Coruña
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Lead Sponsor
Incyte Corporation
INDUSTRY